Key Highlights

Risk & Performance

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

Phase 1

2(66.7%)

N/A

1(33.3%)

3Total

Phase 1(2)

N/A(1)

Loading network data...

Showing 5 of 5 trials

The Effectiveness and Safety of Human Lumbar Puncture Assist Device (LPat)

Role: lead

Safety Study to Examine the Systemic Exposure of Granexin® Gel After Topical Application to Venous Leg Ulcers

Role: collaborator

Safety Study to Examine the Systemic Exposure of Granexin® Gel After Topical Application to Diabetic Foot Ulcers

Role: collaborator

Reducing Disparities in Rural Advanced Cancer Patients and Caregivers

Role: collaborator

Evaluation of Topical B12 for the Treatment of Childhood Atopic Dermatitis

Role: lead

All 5 trials loaded